CD46 and breast cancer: Relevant research has demonstrated that the inflammatory cytokines IL6/IL6R amplify the signaling of the Notch-Jagged pathway, which stimulates the generation of hybrid epithelial-mesenchymal cancer stem cells, and that inhibition of CD46 gene expression reduces the effects of proliferation, invasion, and migration capacity of breast cancer cells.